hexamethylene bisacetamide has been researched along with Kahler Disease in 2 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegel, DS | 2 |
| Terry, JA | 1 |
| Koury, J | 1 |
| Barlogie, B | 1 |
| Epstein, J | 1 |
| Feinman, R | 2 |
| Zhang, X | 1 |
| Teitz, T | 1 |
| Zelenetz, A | 1 |
| Richon, VM | 1 |
| Rifkind, RA | 1 |
| Marks, PA | 1 |
| Michaeli, J | 1 |
1 review available for hexamethylene bisacetamide and Kahler Disease
| Article | Year |
|---|---|
Myc/max family of transcription factors and bcl-2 are involved in drug-induced apoptosis of myeloma cells.
Topics: Acetamides; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Fa | 1997 |
1 other study available for hexamethylene bisacetamide and Kahler Disease
| Article | Year |
|---|---|
Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells.
Topics: Acetamides; Antineoplastic Agents; Apoptosis; Down-Regulation; Humans; Immunoenzyme Techniques; Mult | 1998 |